Archive - July 2023
Few Surgeon-Scientists Continue to Receive NIH Funding After Training
ARS Pharmaceuticals Announces PDUFA Date Extension for neffy® (epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis
Patient-Reported Racism Tied to Mistrust, Worse Patient-Clinician Communication
F2G Receives Complete Response Letter from FDA for New Drug Application for Olorofim for The Treatment of Invasive Fungal Infections
Patient Aggression Toward Medical Receptionists Is Common
Aldeyra Therapeutics Provides Regulatory Update on ADX-2191
UCB Provides Update on U.S. FDA Review of the Biologics License Application for Bimekizumab
Eastern, Southeastern U.S. Have Highest Prevalence of Alzheimer Disease